1. Home
  2. IPO

Category: IPO

Permira-backed Dr. Martens mulls London IPO

The firm acquired the iconic British footwear company in 2013 and, in 2019, was reported to be in talks with Carlyle about a potential sale of the business that did not move forward

Tencent-backed Linklogis eyes Hong Kong listing

Linklogis, a technology-based supply chain finance company, is planning to float in Hong Kong, and has filed a draft IPO prospectus with the city’s stock exchange.

Chicken producer Widodo Makmur hatches IPO plan

Indonesian chicken producer Widodo Makmur Unggas is aiming to raise up to Rph1.18tr ($84m) from the country’s largest IPO in over a year.

French IPOs to rebound in 2021

French IPOs dried up last year as the Covid-19 pandemic derailed companies' plans to go public. This year is likely to be different.

Gracell Biotech boosts US IPO size to $209m

Gracell Biotechnologies has raised $209m from its Nasdaq IPO after increasing the size of the float and pricing the deal above the initial marketed range.

Chinese IPOs in US still on despite NYSE flip-flops

The New York Stock Exchange’s flip-flop on whether to delist three Chinese telecommunications giants caused plenty of confusion in the market this week, but mainland companies are still keen to sell shares in the US.

Russian ECM hopes could be another false dawn

The possible flotation of a Russian hospitals group is being billed as a revival of the country’s IPO market, with more deals to follow. Bankers pointed to the recent US-Russian summit in Switzerland as cause

Easing tensions lift Russian IPO hopes but tough market ahead

Equity capital markets are bracing for an influx of Russian IPOs in the autumn, following a slight easing of tensions between the US and Russia. However, not only is the threat of further sanctions still

Huvepharma pulls €463m IPO

Bulgarian animal healthcare company Huvepharma has become the latest casualty in an IPO market oversaturated with supply.

Ivanhoe Spac targets US IPO for green energy investments

Singapore-based Ivanhoe Capital, led by mining billionaire Robert Friedland, is floating a special purpose acquisition company (Spac) on the New York Stock Exchange.

Gracell Biotech launches $159m US IPO

Chinese clinical-stage company Gracell Biotechnologies has kicked off the roadshow for its Nasdaq listing, eyeing up to $158.9m in proceeds.

Foresight Group mulls London Stock Exchange IPO

Bernard Fairman, the firm's chair, says Foresight’s “significant” recent growth makes listing the company the “logical next step”

Yidu Tech, Strawbear set to be 2021's first HK listings

A trio of Chinese companies, including healthcare technology provider Yidu Tech and television series producer Strawbear Entertainment Group, kicked off their IPOs in Hong Kong at the end of December as they prepare to be

Tencent-backed Tuya, Connect Biopharma ready US IPOs

Tuya, an internet-of-things cloud platform provider, is eyeing around $100m from an IPO of American depository shares (ADS).

London listings revival continues with new fund IPO

UK money manager Triple Point Investment Management is preparing to float a new fund on the London Stock Exchange focused on opportunities within digital infrastructure.

NextEnergy Renewables to float in London IPO

NextEnergy Renewables (NREN), the solar power company, is seeking to float on the London Stock Exchange in a £300m IPO.

Chinese healthcare trio premarket Hong Kong lisitngs

Mainland-based healthcare sector issuers SciClone Phamaceuticals (Holdings), New Horizon Health and Joinn Laboratories (China) kicked off pre-deal investor education for their Hong Kong IPOs on Monday.

Basecare eyes top pricing for IPO, MicroPort nets $323m

Suzhou Basecare Medical Corp has wrapped up its Hong Kong IPO. It was set to price the deal on Monday at the top of the marketed range, according to a source familiar with the matter.

PE-backed Elektroimportøren prices IPO

Private-equity-backed Norwegian electrical equipment manufacturer Elektroimportøren, has announced a NOK 1bn (€94.58m) IPO priced at NOK 48.25 per share.

Brazil’s IPO boom fires up exit opportunities for private equity

Local investors have driven demand for Brazilian initial public offerings this year, in contrast to past booms

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.